Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of
characteristic histopathological features but have a wide range of etiologies, presentations …

Castleman disease (CD), a heterogeneous group of disorders that share morphological
features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical …

Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric …

Background: During the past years biologic agents (also termed biologicals or biologics)
have become a crucial treatment option in immunological diseases. Numerous articles have …

Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the
causal agent of KS but is also pathogenetically related to several lymphoproliferative …

Importance Anti− PD-1 (anti− programmed cell death 1) and anti− PD-L1 (anti− programmed
cell death ligand 1) regimens are preferred therapies for many cancers, including cancers …

The spectrum of Castleman disease (CD) has considerably extended since its first
description in 1956. Recently, an international collaborative working group has reached …

HIV infection increases cancer risk and is linked to cancers associated to infectious agents
classified as carcinogenic to humans by the International Agency for Research on Cancer …

Background Castleman disease is an uncommon lymphoproliferative disorder characterized
as either unicentric or multicentric. Unicentric Castleman disease (UCD) is localized and …

Background. Kaposi sarcoma-associated herpesvirus (KSHV) is the causal agent for Kaposi
sarcoma (KS) and multicentric Castleman disease (MCD) in human immunodeficiency virus …